RayzeBio Inc. Common Stoc...

NASDAQ: RYZB · Real-Time Price · USD
62.49
0.01 (0.02%)
At close: Feb 23, 2024, 10:00 PM

RayzeBio Common Stock Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2023 Q4 2022 Q3 2022
Period Ending Sep 30, 2023 Dec 31, 2022 Sep 30, 2022
Revenue
n/a n/a n/a
Cost of Revenue
n/a n/a n/a
Gross Profit
n/a n/a n/a
Operating Income
-21.65M -17.46M -20.95M
Interest Income
3.49M 2.76M 503K
Pretax Income
-18.19M -14.7M -20.45M
Net Income
-18.19M -14.7M -20.45M
Selling & General & Admin
3.48M 2.7M 2.12M
Research & Development
18.17M 14.76M 18.83M
Other Expenses
-30K n/a n/a
Operating Expenses
21.65M 17.46M 20.95M
Interest Expense
n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a
Cost & Expenses
21.65M 17.46M 20.95M
Income Tax Expense
n/a n/a n/a
Shares Outstanding (Basic)
15.4M 27.31M 40.31M
Shares Outstanding (Diluted)
15.4M 27.31M 40.31M
EPS (Basic)
-1.18 -0.54 -0.51
EPS (Diluted)
-1.18 -0.54 -0.51
EBITDA
-21.15M -17.04M -20.55M
EBIT
-21.65M -17.46M -20.95M
Depreciation & Amortization
500K 419K 404K